Sponsored • POCT

Pluslife Biotech – Mini Dock POC Molecular System

The Pluslife Mini Dock System is a Next-Generation POC molecular diagnostic tool that can be used in different application scenarios, which aims to help the decentralization of MDx in diagnosing facilities.


Complete POC Molecular Testing Solution (Isothermal Amplification Chip Method) 

  • Analyzers, Mini Dock and 8-Channel 
  • 16 Tests, 
    • Pandemic Control - SARS-CoV-2, Monkeypox
    • Respiratory Health - SARS-CoV-2/Flu A/Flu B, RSV/Flu A/Flu B, Strep A, M.P
    • Sexual Health - STD (NG/UU), STD (CT/NG/UU), HPV 16/18/45, HPV 6/11, Strep B (GBS)
    • Animal Health - Feline (FHV-1/C.felis/M.felis), Feline (FHV-1/C.felis/M.felis/Bb), Canine (CDV/CPIV/CAV-2/Bb), ASFV


  • Performance: 98.91% Sensitivity, 100% Specificity, LoD 400 Copies/mL
  • Compact, 
    • Palmed-sized Mink Dock (~210g), weight less than iPhone 14 (~240g)
    • 8-Channel Analyzer, benchtop and stackable design
  • Accurate, equivalent to qPCR tests
  • Fast, 3-step process (sampling → mixing → run test), results in 15~30 mins
  • Powerful, one test up to 6 pathogens
  • Competitive Cost, reusable analyzers and room temperature storage test cards

Find us at MEDICA 2022 Booth No.1 1H39-7 or visit https://www.pluslife.com/ for more detail. 

Website: https://www.pluslife.com/ 


Read all latest stories

Related articles


Sponsored • Diagnostics Alliance against SARS-CoV-2

The Global Alliance for Diagnostics Sets Next-Generation POC Molecular Testing Collaboration

The coronavirus pandemic is a huge challenge for global public health and welfare. Decentralized, affordable POC MDx platforms would allow more effective control of SARS-CoV-2 and other infections.


News • Preparing for the next pandemic

New rapid electronic diagnostic test for infectious diseases

A new molecular test for bacteria and viruses, including Sars-CoV-2, has been developed at the University of Surrey, as they warn that the world needs to be prepared for the next pandemic.


News • "COMPASS" method

Using nanoparticles for more sensitive rapid tests

A newly developed rapid test needs only a few seconds to reliably detect pathogens such as SARS-CoV-2. It is based on specially designed magnetic nanoparticles.

Related products

Subscribe to Newsletter